Skip to main content

Prostate Cancer Clinical Trials

Review the prostate cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 555

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Differences in Immunological Effects of Vitamin D Replacement among African American Prostate Cancer Patients with Localized versus Metastatic Disease
Status: Active
Location: 2 locations
Pre-Surgical Tirzepatide-Assisted Weight Loss for the Treatment of Overweight and Obese Men with Diabetes and Prostate Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
4AP for the Treatment of Nerve Injury from Retropubic Prostatectomy in Patients with Localized Prostate Cancer
Status: Active
Location: Banner University Medical Center - Tucson, Tucson, Arizona
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men with Localized Prostate Cancer on Active Surveillance
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Discontinuation of Standard LHRH Agonist Therapy in Elderly Prostate Cancer Patients
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Focal Therapy (Transvesical Single-Port Robotic Partial Prostatectomy versus High-Intensity Focused Ultrasound) for the Treatment of Patients with Prostate Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Image Guided Tumor Focused Radiation Therapy compared to Standard Whole Prostate Radiation Therapy for the Treatment of Patients with Intermediate and High-risk Prostate Cancer, RADTARGET Trial
Status: Active
Location: UC San Diego Moores Cancer Center, La Jolla, California
Cone-Beam Computed Tomography-Based Adaptive Stereotactic Body Radiation Therapy for the Treatment of Intermediate- and Favorable High-Risk Prostate Cancer, DE-CART Trial
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Focal Ablation with Focal Cryotherapy or High Intensity Frequency Ultrasound for the Treatment of Men with Localized Prostate Cancer
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Image-Guidance and Online Adaptation with Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Computed Tomography-Guided Stereotactic Body Radiation Therapy with Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Two-Fraction High Dose Rate Brachytherapy Delivered Three Hours Apart for Localized Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Surgical Removal of Prostate Tumor and Antiandrogen Therapy with or without Docetaxel in Treating Men with Newly Diagnosed Metastatic Prostate Cancer
Status: Active
Location: 18 locations
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
Status: Active
Location: See ClinicalTrials.gov
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Status: Active
Location: See ClinicalTrials.gov
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Status: Active
Location: See ClinicalTrials.gov